Still fall break with the kids, so I will try and keep this focused. The sector is off to a good start this week and it is hard to know if this is simply following the broader market, a bounce from support, or a move from some positive news. It is likely a little of […]
March 24 Biotech Update
Do we have AHCA fatigue yet? It could end today if the House votes no but a yes vote likely means another couple months of debate as it moves to the Senate where it is a non-starter. What is interesting for the broader market is the claim by Trump that he would move on to […]
[Free Report] Flexion Receives Clinical Hold; Merck KGaA Looks to Partner Immuno-Onc Drug
Flexion Therapeutics announced the FDA informed the company yesterday that a clinical hold has been placed on patient enrollment and dosing in an ongoing Phase IIb trial evaluating FX006 in patients with osteoarthritis (OA) of the knee. Flexion has not yet received written notice of the hold, but verbal communication from the FDA indicates it […]
